Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA)

CUSIP: 29384C108

Q1 2022 13F Holders as of 31 Mar 2022

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
38,346,880
Total 13F shares
25,876,494
Share change
+504,681
Total reported value
$242,821,140
Price per share
$9.39
Number of holders
48
Value change
+$2,263,033
Number of buys
21
Number of sells
17

Security key

29384C108

Report period

Q1 2022

Institutions

48

Top holders

10

Top shareholders of TRDA - Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAKER BROS. ADVISORS LP
13F
Company
12%
4,704,419
$80,540,000 31 Dec 2021
13F
MPM ASSET MANAGEMENT LLC
13F
Company
12%
4,425,784
$75,769,000 31 Dec 2021
13F
5AM Venture Management, LLC
13F
Company
11%
4,408,379
$75,471,000 31 Dec 2021
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
8.1%
3,114,006
$52,797,000 31 Dec 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
5.3%
2,020,637
$34,593,000 31 Dec 2021
13F
Redmile Group, LLC
13F 3/4/5
Company · 10%+ Owner
5.1%
1,954,420
$33,460,000 31 Dec 2021
StepStone Group LP
13F
Company
2%
761,277
$13,033,000 31 Dec 2021
13F
TCG Crossover Management, LLC
13F
Company
1.7%
663,694
$11,362,000 31 Dec 2021
13F
72 Investment Holdings, LLC
13F
Company
1.3%
509,024
$8,714 31 Dec 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.2%
445,455
$7,626,000 31 Dec 2021
13F
BlackRock Finance, Inc.
13F
Company
1.2%
444,426
$7,609,000 31 Dec 2021
13F
VANGUARD GROUP INC
13F
Company
1.1%
424,952
$7,274,000 31 Dec 2021
13F
FMR LLC
13F
Company
0.75%
285,800
$4,893,000 31 Dec 2021
13F
Avidity Partners Management LP
13F
Company
0.66%
255,000
$4,366,000 31 Dec 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.42%
162,187
$2,776,000 31 Dec 2021
13F
CITADEL ADVISORS LLC
13F
Company
0.28%
108,794
$1,862,000 31 Dec 2021
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
0.28%
106,000
$1,815,000 31 Dec 2021
13F
MOORE CAPITAL MANAGEMENT, LP
13F
Company
0.27%
105,000
$1,798,000 31 Dec 2021
13F
STATE STREET CORP
13F
Company
0.21%
81,119
$1,389,000 31 Dec 2021
13F
NORTHERN TRUST CORP
13F
Company
0.21%
79,483
$1,361,000 31 Dec 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.17%
64,019
$1,097,000 31 Dec 2021
13F
TD ASSET MANAGEMENT INC
13F
Company
0.15%
57,675
$987,000 31 Dec 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.12%
46,504
$796,000 31 Dec 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.06%
22,842
$391,000 31 Dec 2021
13F
Ghisallo Capital Management LLC
13F
Company
0.04%
15,000
$257,000 31 Dec 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.04%
13,872
$237,000 31 Dec 2021
13F
Bank of New York Mellon Corp
13F
Company
0.04%
13,657
$234,000 31 Dec 2021
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.04%
13,573
$232,000 31 Dec 2021
13F
Cubist Systematic Strategies, LLC
13F
Company
0.03%
11,090
$190,000 31 Dec 2021
13F
CAAS CAPITAL MANAGEMENT LP
13F
Company
0.03%
10,000
$171,000 31 Dec 2021
13F
DEUTSCHE BANK AG\
13F
Company
0.01%
5,567
$95,000 31 Dec 2021
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.01%
5,320
$91,000 31 Dec 2021
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.01%
5,016
$86,000 31 Dec 2021
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.01%
4,867
$83,000 31 Dec 2021
13F
MORGAN STANLEY
13F
Company
0.01%
4,162
$71,000 31 Dec 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
3,494
$60,000 31 Dec 2021
13F
UBS Group AG
13F
Company
0.01%
2,814
$48,000 31 Dec 2021
13F
Tower Research Capital LLC (TRC)
13F
Company
0.01%
2,478
$42,000 31 Dec 2021
13F
CITIGROUP INC
13F
Company
0.01%
2,393
$41,000 31 Dec 2021
13F
STRS OHIO
13F
Company
0.01%
2,100
$35,000 31 Dec 2021
13F
ROYAL BANK OF CANADA
13F
Company
0%
1,863
$32,000 31 Dec 2021
13F
Legal & General Group Plc
13F
Company
0%
848
$15,000 31 Dec 2021
13F
Ameritas Investment Partners, Inc.
13F
Company
0%
708
$12,000 31 Dec 2021
13F
OSAIC HOLDINGS, INC.
13F
Company
0%
300
$5,000 31 Dec 2021
13F
State of Wyoming
13F
Company
0%
231
$4,000 31 Dec 2021
13F
Point72 Hong Kong Ltd
13F
Company
0%
215
$4,000 31 Dec 2021
13F
ROCHE HOLDING LTD
3/4/5
10%+ Owner
class O/S missing
2,813,525
$44,988,265 02 Nov 2021

Institutional Holders of Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA) as of Q1 2022

As of 31 Mar 2022, Entrada Therapeutics, Inc. - Common Stock, par value $0.0001 per share (TRDA) was held by 48 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 25,876,494 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, MPM ASSET MANAGEMENT LLC, 5AM Venture Management, LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, Redmile Group, LLC, FMR LLC, StepStone Group LP, TCG Crossover Management, LLC, and 72 Investment Holdings, LLC. This page lists 48 institutional shareholders reporting positions in this security for the Q1 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2022 vs Q4 2021 Across Filers

Q4 2021 holders
45
Q1 2022 holders
48
Holder diff
3
Investor Q4 2021 Shares Q1 2022 Shares Share Diff Share Chg % Q4 2021 Value $ Q1 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .